Schmidl, Christian 
; Vladimer, Gregory I. ; Rendeiro, André F. ; Schnabl, Susanne ; Krausgruber, Thomas ; Taubert, Christina ; Krall, Nikolaus ; Pemovska, Tea ; Araghi, Mohammad ; Snijder, Berend ; Hubmann, Rainer ; Ringler, Anna ; Runggatscher, Kathrin ; Demirtas, Dita ; de la Fuente, Oscar Lopez ; Hilgarth, Martin ; Skrabs, Cathrin ; Porpaczy, Edit ; Gruber, Michaela ; Hoermann, Gregor ; Kubicek, Stefan ; Staber, Philipp B. ; Shehata, Medhat ; Superti-Furga, Giulio ; Jäger, Ulrich ; Bock, Christoph
; Vladimer, Gregory I. ; Rendeiro, André F. ; Schnabl, Susanne ; Krausgruber, Thomas ; Taubert, Christina ; Krall, Nikolaus ; Pemovska, Tea ; Araghi, Mohammad ; Snijder, Berend ; Hubmann, Rainer ; Ringler, Anna ; Runggatscher, Kathrin ; Demirtas, Dita ; de la Fuente, Oscar Lopez ; Hilgarth, Martin ; Skrabs, Cathrin ; Porpaczy, Edit ; Gruber, Michaela ; Hoermann, Gregor ; Kubicek, Stefan ; Staber, Philipp B. ; Shehata, Medhat ; Superti-Furga, Giulio ; Jäger, Ulrich ; Bock, Christoph Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL
Article
Schmidl, Christian, Vladimer, Gregory I. , Rendeiro, André F. , Schnabl, Susanne, Krausgruber, Thomas , Taubert, Christina, Krall, Nikolaus, Pemovska, Tea , Araghi, Mohammad, Snijder, Berend , Hubmann, Rainer, Ringler, Anna, Runggatscher, Kathrin, Demirtas, Dita, de la Fuente, Oscar Lopez, Hilgarth, Martin, Skrabs, Cathrin, Porpaczy, Edit, Gruber, Michaela, Hoermann, Gregor, Kubicek, Stefan , Staber, Philipp B., Shehata, Medhat, Superti-Furga, Giulio, Jäger, Ulrich and Bock, Christoph
(2019)
Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL.
Nature Chemical Biology 15 (3), pp. 232-240.
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Nature Chemical Biology | ||||
| Publisher | Nature | ||||
| Place of Publication | NEW YORK | ||||
| Volume | 15 | ||||
| Number of Issue or Book Chapter | 3 | ||||
| Page Range | pp. 232-240 | ||||
| Date | 2019 | ||||
| Date of publication | 03 Sep 2021 10:04 | ||||
| Institutions | Leibniz Institute for Immunotherapy (LIT) | ||||
| Identification Number |
| ||||
| Keywords | CHRONIC LYMPHOCYTIC-LEUKEMIA; B-CELL RECEPTOR; TYROSINE KINASE INHIBITION; THERAPEUTIC TARGET; OPEN-LABEL; IBRUTINIB; BTK; RESISTANCE; ANNOTATION; EXPRESSION; | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 48956 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric